Folic acid-decorated tamoxifen-loaded covalent organic framework induces apoptosis in MCF-7 breast cancer cells via BAX/Caspase-8 upregulation
Cellular and Molecular Biology · 2026
DOI: 10.14715/cmb/2025.72.1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2026. Verfasst von Akash Chandran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advanced Cancer Research, Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram-695034, Kerala, India. …. Hauptthemen laut MEDLINE: Folic Acid, Tamoxifen, Apoptosis, bcl-2-Associated X Protein. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The side effects and non-specific targeting of healthy organs associated with conventional cancer therapies necessitate the design and fabrication of novel nanomaterial-based drug delivery systems. In this study, we successfully fabricated a novel two-dimensional (2D) covalent organic framework (COF) nanomaterial. This COF was loaded with tamoxifen (TMX) and surface-modified with folic acid (FA) to achieve effective targeting for breast cancer therapy. The resulting construct, TMX@COF-FA, was characterized using PXRD, FTIR, ¹³C NMR, CHNS analysis, BET surface area analysis, TGA, UV-Vis spectroscopy, SEM, and EDX analysis. The COF carrier demonstrated a high drug encapsulation efficiency of approximately 82%. Furthermore, it exhibited a pH-responsive drug release profile, with a significantly higher release rate at pH 5.4 compared to pH 7.4, which is ideal for the acidic tumor microenvironment. Cell viability studies revealed that TMX@COF-FA induced about 90% cell death in MCF-7 breast cancer cells, while showing minimal cytotoxicity in L929 fibroblast cells. The mechanism of cell death was investigated using AO/EtBr dual staining, ROS detection assays, flow cytometry (FACS), and qRT-PCR. Collectively, our findings demonstrate that the FA-conjugated COF can efficiently deliver TMX to MCF-7 cells via folate receptor-mediated endocytosis, leading to potent cancer cell destruction. This study underscores the potential of functionalized COFs as promising targeted drug delivery platforms for breast cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Advanced Cancer Research, Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram-695034, Kerala, India. akashchandran26@gmail.com.
- Centre for Advanced Cancer Research, Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram-695034, Kerala, India. sudhinaazeem10@gmail.com.
- Department of Biochemistry, Government Arts and Science College, Kulathoor, Neyyattinkara-695506, Thiruvananthapuram, India. janeeshbiochemistry@keralauniversity.ac.in.
- Department of Biochemistry, St. Albert's College (Autonomous), Mahatma Gandhi University, Ernakulam-682018, India. janeeshbiochemistry@keralauniversity.ac.in.
- Centre for Advanced Cancer Research, Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram-695034, Kerala, India. janeeshbiochemistry@keralauniversity.ac.in.
Zitieren
APA
Chandran, A., S, S., A, R., Vibin, M., & Plakkal Ayyappan, J. (2026). Folic acid-decorated tamoxifen-loaded covalent organic framework induces apoptosis in MCF-7 breast cancer cells via BAX/Caspase-8 upregulation. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2025.72.1.4
Vancouver
Chandran A, S S, A R, Vibin M, Plakkal Ayyappan J. Folic acid-decorated tamoxifen-loaded covalent organic framework induces apoptosis in MCF-7 breast cancer cells via BAX/Caspase-8 upregulation. Cellular and Molecular Biology. 2026. doi:10.14715/cmb/2025.72.1.4
BibTeX
@article{Chandran2026,
author = {Chandran, Akash and S, Sudhina and A, Radhika and Vibin, Muthunayagam and Plakkal Ayyappan, Janeesh},
title = {Folic acid-decorated tamoxifen-loaded covalent organic framework induces apoptosis in MCF-7 breast cancer cells via BAX/Caspase-8 upregulation},
journal = {Cellular and Molecular Biology},
year = {2026},
doi = {10.14715/cmb/2025.72.1.4}
}
EUVIMED